发明名称 LIPOSOMAL COMPOSITION FOR CONVECTION-ENHANCED DELIVERY TO THE CENTRAL NERVOUS CENTRE
摘要 Convection-enhanced delivery (CED) is used as a method to deliver a direct infusion of therapeutic agents to the central nervous centre thus circumventing the blood-blood barrier. A non-PEGylated liposomal composition comprising at least one saturated neutral phospholipid and at least one saturated anionic phospholipid and a therapeutic or diagnostic agent encapsulated therein is used to overcome toxicity associated with high peak drug concentration delivered locally CED as well as to increase tissue distribution volume for an improved sustained drug release. In one embodiment, the liposome composition comprises a molar ratio of DSPC:DSPG:CHOL of 7:2:1 and the therapeutic or diagnostic agent is selected from topotecan, conotoxin, gadodiamide or rhodamine, and is used in the treatment of epilepsy
申请公布号 CA2743959(A1) 申请公布日期 2010.05.27
申请号 CA20092743959 申请日期 2009.11.23
申请人 MEDGENESIS THERAPEUTIX INC. 发明人 LUZ, MATTHIAS;REDELMEIER, THOMAS
分类号 A61K9/127;A61K31/4745;A61K38/16;A61K49/18;A61P25/00 主分类号 A61K9/127
代理机构 代理人
主权项
地址